<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Voyager Therapeutics, Inc.

    Voyager Therapeutics, Inc.

    Voyager Therapeutics is developing life-changing gene therapies for fatal and debi...

    Voyager Therapeutics is developing life-changin...

    Filing Type:    PU
    Twist Bioscience Corporation

    Twist Bioscience Corporation

    We are a leading, rapidly growing synthetic biology company that has developed a d...

    We are a leading, rapidly growing synthetic bio...

    Filing Type:    PU
    Accuray Incorporated

    Accuray Incorporated

    Accuray develops, manufactures and sells radiation oncology systems that make canc...

    Accuray develops, manufactures and sells radiat...

    Filing Type:    PU
    ContraFect Corporation

    ContraFect Corporation

    ContraFect is a clinical-stage biotechnology company focused on discovering and de...

    ContraFect is a clinical-stage biotechnology co...

    Filing Type:    PU
    Homology Medicines, Inc.

    Homology Medicines, Inc.

    Homology Medicines, Inc. is a genetic medicines company dedicated to transforming ...

    Homology Medicines, Inc. is a genetic medicines...

    Filing Type:    PU
    ZENII, LLC

    ZENII, LLC

    Intrommune Therapeutics is a New York City-based biopharmaceutical company develop...

    Intrommune Therapeutics is a New York City-base...

    Amount Raised:    $154,555.00
    Fundraising Status:    EC
    Filing Type:    CF
    DermTech, Inc.

    DermTech, Inc.

    DermTech is the global leader in molecular dermatology, bringing precision medicin...

    DermTech is the global leader in molecular derm...

    Filing Type:    PU
    Agios Pharmaceuticals, Inc.

    Agios Pharmaceuticals, Inc.

    Agios is a biopharmaceutical company passionately committed to applying our scient...

    Agios is a biopharmaceutical company passionate...

    Filing Type:    PU
    Replimune Group, Inc.

    Replimune Group, Inc.

    Cancer is one of the most difficult diseases to treat. It is constantly changing, ...

    Cancer is one of the most difficult diseases to...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.